1. Home
  2. Browse
  3. National Institutes of Health
  4. RFA-MH-27-125

RFA-MH-27-125National Institutes of Health

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

Deadline
Award ceiling
Not stated
Awards
Not stated
Posted
Sep 30, 2026

Official announcement on Grants.gov · opens the funder's page. Always confirm dates there.

Summary

The purpose of this notice of funding opportunity (NOFO) is to identify modifiable mechanisms and therapeutic targets to address central nervous system (CNS) complications associated with human immunodeficiency virus (HIV)…

Preparing an application?

On Plus, $39 a month

  • The eligibility check against your profile: career stage, institution type, and the windows that close before the deadline does
Start with PlusSign in

Cancel any time. Browsing stays free.

Subjects

More from National Institutes of Health

Open now with at least two weeks to apply, soonest deadline first.

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

PAR-25-070National Institutes of Health3 review criteria on file

—

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

PAR-25-321National Institutes of Health3 review criteria on file

—

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

PAR-25-256National Institutes of Health3 review criteria on file

—

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

PAR-25-266National Institutes of Health3 review criteria on file

$200k

Everything open from National Institutes of Health

Related by subject

Open opportunities sharing the most subjects with this one (Infectious disease), with at least two weeks to apply.

Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)

PAR-25-068National Institutes of Health3 review criteria on fileagency framework

—

Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)

PAS-27-028National Institutes of Health3 review criteria on fileagency framework

—

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

PAR-24-329National Institutes of Health3 review criteria on file

—

Everything open tagged Infectious disease

Source record: https://www.grants.gov/search-results-detail/359657Via Grants.gov. Last checked against the source . Always confirm dates with the funder.